TrialJAMA oncology2020

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.

Joseph A Sparano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.